Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
doi:10.1124/jpet.111.182220
SOX10 is present in 70% of cases
Carnitine, carnitine acyltransferases, and rat brain function
US$ 19.99
US$ 22.35
US$ 24.14
US$ 20.39
US$ 22.42
US$ 21.30
US$ 23.74
US$ 21.32
